

Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:
Ref. 3D-FM102381


Informação sobre produto
Nome:Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
Marca:Biosynth
Descrição:Methyl 1-(2,4-difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate (SNX-111) is a drug that has been shown to be useful in the treatment of inflammatory bowel disease. It has a low potency, but it is activated by colonic bacteria and has been shown to have clinical use for the treatment of bowel disease. SNX-111 also acts as a potent antagonist of actin filaments and y-27632. It has been shown to reduce cardiac hypertrophy and primary sclerosing cholangitis. SNX-111 inhibits VSMC proliferation in vitro and in vivo.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:395.43 g/mol
Fórmula:C17H19F2N5O2S
Pureza:Min. 95%